Last week, Canadas announced a suite of bills to legalize recreational marijuana use throughout Canada making good on a campaign promise. The pending legalization bills are widely expected to pass (the goal is to get the regulatory regime off the ground by July 1, 2018) with Abovethelaw.com having an article with the following good summary of the proposedrestrictions and standards:
The legal age to purchase up to an ounce of marijuana will be 18, but the Provinces are free to set higher age limits. Individuals 18 and older can grow up to four plants per household for personal use. Tourists cannot bring cannabis into Canada, but they can purchase and use it while there. The provinces will almost exclusively regulate retail and marijuana distribution, as well as the retail price of marijuana. They can even own their own retail establishments if they wish. Provinces will be able to decide whether alcohol and marijuana can be sold at the same retail location. According to the federal governments own press release, those jurisdictions that have not put in place a regulated retail framework, individuals would be able to purchase cannabis online from a federally licensed producer with secure home delivery through the mail or by courier. Marijuana vending machines and self-service displays are banned. The federal government will regulate marijuana producers. Advertising, promotions, and marketing cannot appeal to children and they will be heavily regulated by the federal government, including the possibility of no branding at all on the production side. Regulations regarding packaging and labeling are mandated, but they need to be debated by government first. No federal taxes or licensing fees are contained in the bills. Cannabis cannot be used to infuse alcohol, nicotine, or caffeine and vice-versa. More than 2 nanograms of active THC in the blood is a criminal driving offense punishable with a fine and the presence of more than 5 nanograms is a more serious offense, and officers will test driving impairment by using fluid samples, including saliva and blood samples.
Many Americans may not realize that while Canadahaslegalized medical marijuana and its production, its never actually legalized medical marijuana distribution or dispensaries. However, many dispensaries operate freely due to local law enforcement tolerance in certain Provinces.
Top 10 Casino Stocks For 2017: Palo Alto Networks, Inc.(PANW)
- [By Leo Sun]
Last November, I compared Palo Alto Networks (NYSE:PANW) with FireEye (NASDAQ:FEYE) to see which one was the better play on the growing cybersecurity market. I concluded that FireEye was a slightly better pick than Palo Alto, due to its cost-cutting measures, lower valuation, and takeover potential.
- [By WWW.THESTREET.COM]
In the Lightning Round, Cramer was bullish on Palo Alto Networks (PANW) , Cisco Systems (CSCO) , Tanger Factory Outlet Centers (SKT) and Consolidated Edison (ED) .
- [By Wayne Duggan]
Trump recently appointed former New York mayor Rudy Giuliani as head of his cybersecurity task force. Trump has pledged to immediately initiate a review of “all U.S. cyber defenses and vulnerabilities, including critical infrastructure.” The review and response process could mean new government contracts on the way for cybersecurity stocks such as FireEye Inc (NASDAQ: FEYE) and Palo Alto Networks Inc (NYSE: PANW).
- [By Harsh Chauhan]
Palo Alto Networks (NYSE:PANW) will look for redemption when it releases its second-quarter fiscal 2017 results after the bell on Feb. 28. The network security specialist had offered a weaker-than-expected outlook in its last quarterly report as some of its deals requiring “additional approvals” got pushed back.
- [By Steve Symington]
When revenue inPalo Alto Networks Inc.’s (NYSE:PANW) latest quarter fell short of Wall Street’s expectations a few weeks ago, shares of the next-gen security specialist plummeted more than 20% in a single day. To blame, according to Palo Alto, were execution challenges that the company insists it’s “moving quickly to address.”
Top 10 Casino Stocks For 2017: Canadian Pacific Railway Limited(CP)
- [By Rich Duprey]
Railroad operator CSX may not have risen as sharply as Alcoa over the past few months, but it has also been steadily rising. It got a big boost this month when the CEO of Canadian Pacific Railway (NYSE:CP) Hunter Harrison resigned his position and was said to be teaming up with activist investor Paul Hilal to take on CSX, causing the railroad’s stock to surge 23% on the news.
- [By Ben Levisohn]
A strange turn of events has sent shares of CSX (CSX)–and other railroads, including Union Pacific (UNP) and Canadian Pacific Railway (CP)–soaring today. It all started when Hunter Harrison announced that he would leave Canadian Pacific ahead of schedule to team up with activist investor for the turnaround of another railway company. That company is thought to be CSX.
Top 10 Casino Stocks For 2017: Syngenta AG(SYT)
- [By WWW.THESTREET.COM]
Syngenta AG (SYT) CEO Erik Fyrwald said Wednesday that he was “entirely confident” the company’s $43 billion takeover by China National Chemical Corp. would close in the second quarter of this year and dismissed suggestions it would be disrupted by a third party.
- [By Shanthi Rexaline]
Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers
Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.
Top 10 Casino Stocks For 2017: OncoMed Pharmaceuticals, Inc.(OMED)
- [By Paul Ausick]
OncoMed Pharmaceuticals Inc. (NASDAQ: OMED) dropped about 5.3% Wednesday to post a new 52-week low of $4.69 after closing at $4.95 on Tuesday. The stock’s 52-week high is $15.49. Volume was more than double the daily average of around 270,000 shares. The company had no specific news Wednesday.
- [By Teresa Rivas]
OncoMed Pharmaceuticals (OMED) has lost more than a third of its value Monday, after Bayer decided not to exercise its option to license the firms Phase II-ready WNT pathway inhibitors Vantictumab and Ipafricept, which treat pancreatic cancer.
That wasnt the only bad news, however, as the firms randomized-controlled Phase II “YOSEMITE” trial of pancreatic cancer drug demcizumab also missed its primary endpoint.
Leerinks Michael Schmidt and his team reiterated a Market Perform rating on the stock Monday, and lowered their price target from $10 to $6 on the news, calling it a “double setback” for OncoMed.
More detail from the note:
This is a major setback for OMED and in our view for the cancer stem cell targets more broadly, which have been a difficult area of drug development. We’ve been cautious on the probability-of-success of these agents and see more promise on OMED’s recent efforts in building a second area of focus in immuno-oncology. Going forward, OMED plans to review and prioritize its R&D pipeline after results from the still pending tarextumab Phase II “PINNACLE” trial in small cell lung cancer (SCLC) and data from the demcizumab “DENALI” trial in NSCLC are available in 2Q17. We remain MP rated in light of the uncertainties around OMED’s pipeline and strategy at this point. We previously assigned a 30% probability of success (POS) to demcizumab which we now have removed from our model. We also think chances that CELG will opt-into this program are slim and we have removed associated POS-adjusted milestone payments from our model. OMED has cas h to run operations through 3Q18.
OncoMed is down 36.1% to $5.60 this afternoon.
- [By Paul Ausick]
OncoMed Pharmaceuticals Inc. (NASDAQ: OMED) dropped nearly 44% Monday to post a new 52-week low of $4.94 after closing Friday at $8.76. The stock’s 52-week high is $15.49. Volume of about 3.3 million shares was nearly 20 times the daily average of around 182,000. A proposed deal with Bayer AG fell through and one of the company’s drugs failed a phase 2 clinical trial.
Top 10 Casino Stocks For 2017: Talisman Energy Inc.(TLM)
- [By Jayson Derrick]
On the other hand, the analysts are Underweight on Eni SpA (ADR) (NYSE: E), Repsol Oil & Gas Canada Inc (USA) (NYSE: TLM) and OMV AG given their asset bases, which offer an inferior risk to reward profile and limited differentiation in cost reductions.
Top 10 Casino Stocks For 2017: HCP, Inc.(HCP)
- [By WWW.KIPLINGER.COM]
HCP, Inc. (HCP) is a REIT that focuses on senior housing facilities and other healthcare properties.
With a yield of 5.8%, HCP is the highest yielder of all the aristocrat dividend stocks. HCP has upped its payout for 30 straight years and now pays 57.5 cents per unit quarterly.
- [By Matthew Frankel]
Healthcare REIT HCP, Inc. (NYSE:HCP) had an eventful 2016. The year started off quite turbulent, with dismal results from the company’s HCR ManorCare properties leading to a surprise loss, but recovered nicely as the company decided to spin off those and other troubled assets. What could be in store for HCP investors in the coming decade?
- [By Matthew Frankel]
One smart way to capitalize on this trend over the next few decades is with a healthcare REIT like HCP (NYSE:HCP), which specializes in private-pay senior housing, medical office, and life science properties.
Top 10 Casino Stocks For 2017: Pebblebrook Hotel Trust(PEB)
- [By Marshall Hargrave]
The other key benefit for Strategic is that it enjoys industry-leading earnings before interest, taxes, depreciation and amortization (EBITDA) per available room. For 2012, Strategic generated $81 per room of EBITDA. Compare this to top comps LaSalle Hotel (NYSE: LHO) at $74 per room and Pebblebrook Hotel Trust (NYSE: PEB) at $71. The reason for this is that Strategic is much less reliant than its peers on rooms, with much greater exposure to food and beverages. Strategic earns 53% of its revenue from rooms, while its peers get around 66% of revenues from rooms.
Top 10 Casino Stocks For 2017: iShares MSCI Japan (EWJ)
- [By Stephen Leeb, Founder and Research Chairman, Leeb Group]
Despite the 30% plus gains they’ve enjoyed this year, the stocks that comprise the iShares MSCI Japan ETF (EWJ) still trade at 14 times depressed earnings.
Top 10 Casino Stocks For 2017: Vanguard Extended Duration Treasury ETF (EDV)
- [By Todd Shriber, ETF Professor]
The 11 ETF fee cuts unveiled by Vanguard include a significant portion of the issuer's fixed income lineup. All of the following saw annual fees reduced to 0.07 percent from 0.1 percent:
Vanguard Extended Duration Treasury ETF (NYSE: EDV). Vanguard Intermediate-Term Bond ETF (NYSE: BIV). Vanguard Intmdte Tm Govt Bd ETF (NASDAQ: VGIT). Vanguard Long Term Corporate Bond ETF (NASDAQ: VCLT). Vanguard Lg Term Govt Bd ETF (NASDAQ: VGLT). Vanguard Mortgage Bkd Sects ETF (NASDAQ: VMBS).
and the Vanguard Short Term Corporate Bond ETF (NASDAQ: VCSH).
Top 10 Casino Stocks For 2017: Canadian National Railway Company(CNI)
- [By Brett Hershman]
The Swiss bank said it was raising first-quarter estimates on four of the six rails it covers, with updated estimates above consensus on Canadian National Railway (USA) (NYSE: CNI), CSX Corporation (NASDAQ: CSX) and Kansas City Southern (NYSE: KSU), which is seen to show upside against low expectations.
- [By Monica Gerson]
Canadian National Railway (USA) (NYSE: CNI) is estimated to post its quarterly earnings at $0.92 per share on revenue of $3.08 billion.
Container Store Group Inc (NYSE: TCS) is expected to post its quarterly earnings at $0.21 per share on revenue of $230.53 million.